STOCK TITAN
  1. Home
  2. Sec-filings
  3. STIM
  4. [Form 4] Neuronetics, Inc. Insider Trading Activity

Director at Neuronetics (STIM) receives 30,000-share RSU grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Neuronetics, Inc. director Glenn P. Muir received a grant of 30,000 restricted stock units (RSUs) of common stock at no cost. The RSU award vests on the earlier of May 28, 2027, or a Board-approved separation of service or change in control, subject to his continuous service.

Each RSU converts into one share of Neuronetics common stock when it vests. Following this equity award, Muir’s reported direct holdings increased to 401,816 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider MUIR GLENN P
Role null
Type Security Shares Price Value
Grant/Award Common Stock 30,000 $0.00 --
Holdings After Transaction: Common Stock — 401,816 shares (Direct, null)
Footnotes (1)
  1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
RSU grant size 30,000 units Restricted stock unit award to director Glenn P. Muir
RSU grant price $0.0000 per unit Equity compensation, no cash paid by the director
Total holdings after grant 401,816 shares Director’s direct non-derivative holdings following RSU award
Vesting date May 28, 2027 Latest vesting date for the 30,000 RSUs, subject to conditions
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027..."
change in control financial
"...or change in control of the Issuer, in each case subject to continuous service..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
continuous service financial
"...subject to continuous service of the Reporting Person through such date."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MUIR GLENN P
(Last)(First)(Middle)
C/O NEURONETICS, INC.
3222 PHOENIXVILLE PIKE
(Street)
MALVERN PENNSYLVANIA 19355
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/28/2026A30,000(1)A$0(2)401,816D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.
2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
/s/ Francis Brown, as Attorney-in-Fact05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Neuronetics (STIM) report for Glenn P. Muir?

Neuronetics reported that director Glenn P. Muir received a grant of 30,000 restricted stock units. These RSUs are a stock-based compensation award, not an open-market share purchase or sale, and increase his direct equity exposure to the company.

How many Neuronetics (STIM) shares does Glenn P. Muir hold after this Form 4?

After the RSU grant, Glenn P. Muir is reported to hold 401,816 shares of Neuronetics common stock. This figure includes his direct non-derivative holdings as reflected in the Form 4 following the 30,000-unit restricted stock award.

When do Glenn P. Muir’s 30,000 Neuronetics RSUs vest?

The 30,000 Neuronetics RSUs vest on the earlier of May 28, 2027, or a Board-approved separation of service or change in control. Vesting is conditioned on Muir’s continuous service with the company through the applicable date.

What does each Neuronetics (STIM) RSU granted to Glenn P. Muir represent?

Each restricted stock unit granted to Glenn P. Muir represents a contingent right to receive one share of Neuronetics common stock. The units convert into shares only upon vesting, subject to the award’s service and event conditions.

Is Glenn P. Muir’s Neuronetics Form 4 transaction an open-market purchase or sale?

No, the filing shows a grant coded as an acquisition (A), described as a grant, award, or other acquisition. It reflects stock-based compensation, not an open-market buy or sale of Neuronetics shares by the director.